Oscar Health (OSCR) Climbs 7.6% as Investors Await Cues on Upcoming Conference

We recently published 10 Power Stocks Crushing Wall Street — 7 at All-Time Highs. Oscar Health, Inc. (NYSE:OSCR) is one of the best performers on Wednesday.

Oscar Health ended two consecutive days of losses on Wednesday, adding 7.61 percent to finish at $17.68 apiece as investors repositioned portfolios amid the ongoing Wells Fargo Health Conference in Boston, Massachusetts.

Oscar Health, Inc. (NYSE:OSCR) had earlier confirmed that it would participate in the three-day event, currently ongoing until September 5. Investors are closely watching out for its outlook and potential updates about its business plans.

Last month, Oscar Health, Inc. (NYSE:OSCR) swung to an attributable net loss of $228.36 million from a $56.2 million attributable net income in the same period last year. Total revenues grew by 28.8 percent to $2.86 billion from $2.22 billion year-on-year.

In the first six months, Oscar Health, Inc. (NYSE:OSCR) dropped its attributable net income by 80 percent to $46.9 million from $233.57 million year-on-year. Total revenues grew by 35.5 percent to $5.91 billion from $4.36 billion in the same comparable period.

For the full-year period, Oscar Health, Inc. (NYSE:OSCR) anticipates total revenues of $11.2 billion to $11.3 billion, and operational income between $225 million and $275 million.

While we acknowledge the potential of OSCR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.